Related Experiment Video
Updated: Feb 14, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
[Analysis of coagulation related parameters between patients with advanced schistosomiasis cirrhosis and hepatitis B
Liu Shun1, Qin Meng2, Tang Shao-Qian1
1The Second Clinical Medical College, Yangtze University, Jingzhou Central Hospital, Jingzhou 434020, China.
Insights
Coagulation parameters differ between schistosomiasis and hepatitis B cirrhosis patients. Hepatitis B cirrhosis shows more significant coagulation impairment with milder liver dysfunction, while advanced stages present distinct patterns in specific coagulation factors.
Area of Science:
- Hepatology
- Hematology
- Infectious Diseases
Background:
- Cirrhosis, a late stage of liver disease, significantly impacts coagulation. Differentiating coagulation profiles between various etiologies like schistosomiasis and hepatitis B is crucial for patient management.
- Coagulation abnormalities are common in cirrhosis, affecting prothrombin time (PT), international normalized ratio (INR), fibrinogen (Fib), thrombin time (TT), activated partial thromboplastin time (APTT), and platelet count (PLT).
Purpose of the Study:
- To compare coagulation parameter differences between advanced schistosomiasis cirrhosis and hepatitis B cirrhosis patients across varying liver function severities.
- To provide evidence for better clinical assessment and prognosis prediction in these patient groups.
Main Methods:
- A comparative study involving 63 advanced schistosomiasis cirrhosis patients, 80 hepatitis B cirrhosis patients, and 96 controls.
- Measurement and comparison of PT, INR, Fib, TT, APTT, and PLT levels in the three groups and stratified by Child-Pugh liver function classes.
Main Results:
- Significant differences in PT, INR, Fib, TT, APTT, and PLT were observed among the three groups (P < 0.05).
- Both cirrhosis groups exhibited prolonged PT, INR, TT, APTT, and lower PLT compared to controls (P < 0.05).
- Hepatitis B cirrhosis patients showed longer PT, INR, TT, APTT, and lower Fib and PLT than schistosomiasis cirrhosis patients (P < 0.05). Coagulation factor differences varied with liver function severity.
Conclusions:
- Coagulation function damage differs between schistosomiasis and hepatitis B cirrhosis.
- Hepatitis B cirrhosis demonstrates more pronounced coagulation impairment with milder liver dysfunction, particularly in PLT reduction.
- As liver function worsens, APTT significantly prolongs in hepatitis B cirrhosis, with less distinct differences in PLT and PT compared to schistosomiasis cirrhosis.
Objective:
To analyze the differences of coagulation parameters between patients with advanced schistosomiasis cirrhosis and hepatitis B cirrhosis under different degrees of liver function, so as to provide the evidence for further guidance of judging clinical condition and prognosis.
Methods:
Sixty-three patients with advanced schistosomiasis cirrhosis and eighty patients with hepatitis B induced cirrhosis hospitalized in Jingzhou Central Hospital from January 2014 to June 2016 were served as an advanced schistosomiasis cirrhosis group and a hepatitis B cirrhosis group, respectively, and ninety-six gastropathy patients excluded from other diseases that might affect coagulation in the same period were served as a control group. The levels of PT, INR, Fib, TT, APTT, and PLT of the patients among the above 3 groups and the cirrhosis patients with different Child-Pugh classes were detected and compared.
Results:
The differences of the levels of PT, INR, Fib, TT, APTT, and PLT among the 3 groups were statistically significant (F = 84.512, 81.672, 37.612, 104.475, 52.497, 102.233; all P <0.05). The further analysis showed that PT, INR, TT, and APTT of both the advanced schistosomiasis cirrhosis and hepatitis B induced cirrhosis groups were longer than those of the control group, and the PLT levels of both the former 2 groups were lower than that of the control group (all P < 0.05). Compared with the advanced schistosomiasis cirrhosis group, PT, INR, TT, and APTT of the hepatitis B induced cirrhosis group were longer, and the levels of Fib and PLT were lower (all P < 0.05). Among those with the liver function of Grade A, the reduced degree of PLT in the patients with hepatitis B induced cirrhosis was more serious, while for those with the liver function of Grade B and C, the difference between the patients with advanced schistosomiasis cirrhosis and hepatitis B induced cirrhosis was not statistically significant (both P > 0.05). Under all the grades of liver function, TT and APTT of the hepatitis B induced cirrhosis group was longer than those of the advanced schistosomiasis cirrhosis group, and the Fib level of the former was lower than that of the latter. Among those with the liver function of Grade A and B, PT and INR of the hepatitis B induced cirrhosis group were longer than those of the advanced schistosomiasis cirrhosis group; while for those with the liver function of Grade C, the difference between the two groups was not statistically significant (all P > 0.05).
Conclusions:
There exist differences of the damage degrees of coagulation function between the patients with advanced schistosomiasis cirrhosis and hepatitis B cirrhosis. When the damage degree of the liver function is lighter, the coagulation function in the patients with hepatitis B cirrhosis decreases more significantly; when the damage degree becomes more severe, APPT in the patients with hepatitis B cirrhosis extends more significantly, while the differences of PLT and PT between them are little.
Related Concept Videos
Coagulation
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
Sample Preparation for Analysis: Advanced Techniques
Acid digestion with strong acids is commonly used to dissolve inorganic materials that are insoluble (do not dissolve) in water. This method can be useful for...
Wave Parameters
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

